Anicetti V[au] - Search Results

Year	Number of Results
1981	1
1986	2
1989	1
1992	1
1994	1
1997	1
2001	1
2014	1
2022	0

1

Analytical considerations in the development of protein purification processes.

Anicetti V, Hancock WS. Anicetti V, et al. Bioprocess Technol. 1994;18:11-36. Bioprocess Technol. 1994. PMID: 7764169

2

Use of pilot plant facilities to aid validation programs.

O'Leary RM, Etcheverry T, Bezy P, Anicetti V, Burton LE. O'Leary RM, et al. Among authors: anicetti v. PDA J Pharm Sci Technol. 2001 Jul-Aug;55(4):230-4. PDA J Pharm Sci Technol. 2001. PMID: 11505555

3

Analysis of neurotrophin/receptor interactions with a gD-flag-modified quantitative kinase receptor activation (gD.KIRA) enzyme-linked immunosorbent assay.

Sadick MD, Galloway A, Shelton D, Hale V, Weck S, Anicetti V, Wong WL. Sadick MD, et al. Among authors: anicetti v. Exp Cell Res. 1997 Aug 1;234(2):354-61. doi: 10.1006/excr.1997.3614. Exp Cell Res. 1997. PMID: 9260905

4

Immunoassay for the detection of E. coli proteins in recombinant DNA derived human growth hormone.

Anicetti VR, Fehskens EF, Reed BR, Chen AB, Moore P, Geier MD, Jones AJ. Anicetti VR, et al. J Immunol Methods. 1986 Jul 24;91(2):213-24. doi: 10.1016/0022-1759(86)90481-3. J Immunol Methods. 1986. PMID: 3525680

5

Immunization procedures for E. coli proteins.

Anicetti VR, Simonetti MA, Blackwood LL, Jones AJ, Chen AB. Anicetti VR, et al. Appl Biochem Biotechnol. 1989 Nov;22(2):151-68. doi: 10.1007/BF02921742. Appl Biochem Biotechnol. 1989. PMID: 2692518

6

PARENTERAL DRUG ASSOCIATION POINTS TO CONSIDER: Pharmaceutical Quality Metrics Updated September 2014.

PDA June 2014 Definitions Task Force and December 2013 Points to Consider Authors, Mendivil S, Bloomfield J, Anicetti V, Baker D, Elvins I, Farris J, Gori G, Kieffer B, Martinez-Rivera E, Nealey M, Patel P, Sawant A, Schniepp S, Vinther A, Wright G. PDA June 2014 Definitions Task Force and December 2013 Points to Consider Authors, et al. Among authors: anicetti v. PDA J Pharm Sci Technol. 2014 Sep-Oct;68(5):535-45. doi: 10.5731/pdajpst.2014.01021. PDA J Pharm Sci Technol. 2014. PMID: 25336423 No abstract available.

7

Recovery of cholinergic phenotype in the injured rat neostriatum: roles for endogenous and exogenous nerve growth factor.

Altar CA, Armanini M, Dugich-Djordjevic M, Bennett GL, Williams R, Feinglass S, Anicetti V, Sinicropi D, Bakhit C. Altar CA, et al. Among authors: anicetti v. J Neurochem. 1992 Dec;59(6):2167-77. doi: 10.1111/j.1471-4159.1992.tb10108.x. J Neurochem. 1992. PMID: 1431899

8

An approach to fungal antigen relationships by radioallergosorbent test inhibition.

Karr RM, Wilson MR, Anicetti VR, Lehrer SB, Butcher BT, Salvaggio JE. Karr RM, et al. Among authors: anicetti vr. J Allergy Clin Immunol. 1981 Mar;67(3):194-8. doi: 10.1016/0091-6749(81)90061-0. J Allergy Clin Immunol. 1981. PMID: 6161952

9

A sensitive radioimmunoprecipitation assay for the detection of antibody to recombinant human gamma-interferon: comparison to a bioassay neutralization test.

Chen AB, Anicetti VR, Klassen TD, Berthold W, Zahn G, Wert RM, Geier MD, Jones AJ. Chen AB, et al. Among authors: anicetti vr. J Interferon Res. 1986 Jun;6(3):313-20. doi: 10.1089/jir.1986.6.313. J Interferon Res. 1986. PMID: 3091713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results